Cinclus Pharma (CINPHA) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.39x
Cinclus Pharma (CINPHA) has a Cash Flow-to-Debt Ratio of -0.39x as of June 2026, meaning its operating cash flow of Skr-86.19 Million could theoretically repay 0% of its total liabilities (Skr221.84 Million) in one year. See CINPHA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.39x
Operating CF / Total Liabilities
Operating Cash Flow
Skr-86.19 Million
SEK
Total Liabilities
Skr221.84 Million
SEK
Data as of
Jun 2026
Most recent filing
Cinclus Pharma Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Cinclus Pharma across 4 annual periods. For the full cash flow conversion analysis, see Cinclus Pharma (CINPHA) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Cinclus Pharma (2022–2025)
Year-by-year debt coverage analysis for Cinclus Pharma.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.42x | Skr-74.65 Million | Skr177.16 Million | ▲ +89.2% |
| 2024 | -3.90x | Skr-178.37 Million | Skr45.68 Million | ▼ -219.6% |
| 2023 | -1.22x | Skr-209.19 Million | Skr171.21 Million | ▲ +62.5% |
| 2022 | -3.26x | Skr-192.08 Million | Skr58.90 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.